AI specialist Chai Discovery raises $400m
Fresh from an alliance with Novartis, Chai Discovery has raised $400 million in third-round funding for its AI-based molecular design platform.
Newsletters and Deep Dive digital magazine
Fresh from an alliance with Novartis, Chai Discovery has raised $400 million in third-round funding for its AI-based molecular design platform.
When it comes to cybersecurity, healthcare data security should concern every provider and pharmaceutical organisation: medical records do not expire.
A study has shown that, for people living with advanced cancer, a weekly remote check-in with the care team can have a significant impact on outcomes.
Many AIs used in drug discovery are provided by big tech companies at a cost, but a small US and China-based techbio is taking a different tack.
Nordic Global is helping NHS organisations transform patient access through digital transformation.
Editor's Picks
Newsletters and Deep Dive
digital magazine